Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06216158
Title Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Heidelberg Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.